{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:02:55Z","timestamp":1789588975761,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.talanta.2022.123827","type":"journal-article","created":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T13:33:39Z","timestamp":1660484019000},"page":"123827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Development of a colorimetric assay for quantification of favipiravir in human serum using ferrihydrite"],"prefix":"10.1016","volume":"252","author":[{"given":"Yukiko","family":"Moriiwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsu","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Yanagida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2022.123827_bib1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.talanta.2022.123827_bib2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/cmdc.201700116","article-title":"Synthesis of T-705-ribonucleoside and T-705-ribonucleotide and studies of chemical stability","volume":"12","author":"Huchting","year":"2017","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.talanta.2022.123827_bib3","doi-asserted-by":"crossref","first-page":"e01305","DOI":"10.1128\/AAC.01305-16","article-title":"Favipiravir pharmacokinetics in nonhuman primates and insights for future efficacy studies of hemorrhagic fever viruses","volume":"61","author":"Madelain","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.talanta.2022.123827_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005389","article-title":"Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted","volume":"11","author":"Nguyen","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.talanta.2022.123827_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/jcm10020273","article-title":"Favipiravir in therapy of viral infections","volume":"10","author":"\u0141agocka","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.talanta.2022.123827_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijid.2020.10.069","article-title":"Role of favipiravir in the treatment of COVID-19","volume":"102","author":"Joshi","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.talanta.2022.123827_bib7","doi-asserted-by":"crossref","first-page":"8557","DOI":"10.2147\/IJGM.S332458","article-title":"Effectiveness of remdesivir, lopinavir\/ritonavir, and favipiravir for COVID-19 treatment: a Systematic Review","volume":"14","author":"Qomara","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.talanta.2022.123827_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108121","article-title":"Antiviral therapy for COVID-19: derivation of optimal strategy based on past antiviral and favipiravir experiences","volume":"235","author":"Shiraki","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.talanta.2022.123827_bib9","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1111\/bcp.15227","article-title":"Pharmacokinetic characterization of favipiravir in patients with COVID-19","volume":"88","author":"G\u00fclhan","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.talanta.2022.123827_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2116\/analsci.21N004","article-title":"Optimization of analytical procedure for in-hospital rapid quantification of serum level of favipiravir in the pharmacological treatment of COVID-19","volume":"37","author":"Moriiwa","year":"2021","journal-title":"Anal. Sci."},{"key":"10.1016\/j.talanta.2022.123827_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jiac.2021.10.011","article-title":"Elevated blood favipiravir levels are inversely associated with ferritin levels and induce the elevation of uric acid levels in COVID-19 treatment: a retrospective single-center study","volume":"28","author":"Morikawa","year":"2022","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.talanta.2022.123827_bib12","doi-asserted-by":"crossref","first-page":"e5365","DOI":"10.1002\/bmc.5365","article-title":"A gadolinium-based magnetic ionic liquid for supramolecular dispersive liquid-liquid microextraction followed by HPLC\/UV for the determination of favipiravir in human plasma","volume":"36","author":"Abdallah","year":"2022","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2022.123827_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.123087","article-title":"Menthol-assisted homogenous liquid-liquid microextraction for HPLC\/UV determination of favipiravir as an antiviral for COVID-19 in human plasma","volume":"1189","author":"Abdallah","year":"2022","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2022.123827_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114057","article-title":"A novel LC-MS\/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma: application to a bioequivalence study in Egyptian human volunteers","volume":"199","author":"Morsy","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.talanta.2022.123827_bib15","article-title":"Development and validation of a sensitive, fast and simple LC-MS\/MS method for the quantitation of favipiravir in human serum","volume":"1176","author":"Onmaz","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2022.123827_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clinbiochem.2020.03.004","article-title":"After another decade: LC-MS\/MS became routine in clinical diagnostics","volume":"82","author":"Seger","year":"2020","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.talanta.2022.123827_bib17","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1039\/C9AN00576E","article-title":"A high-specificity immunoassay for the therapeutic drug monitoring of cyclophosphamide","volume":"144","author":"Broto","year":"2019","journal-title":"Analyst"},{"key":"10.1016\/j.talanta.2022.123827_bib18","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1136\/ejhpharm-2018-001616","article-title":"Therapeutic drug monitoring of levetiracetam in daily clinical practice: high-performance liquid chromatography versus immunoassay","volume":"27","author":"Aguilera","year":"2020","journal-title":"Eur. J. Hosp. Pharm."},{"key":"10.1016\/j.talanta.2022.123827_bib19","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.tibtech.2020.03.001","article-title":"On-site therapeutic drug monitoring","volume":"38","author":"Ates","year":"2020","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.talanta.2022.123827_bib20","article-title":"Biosensor-enabled multiplexed on-site therapeutic drug monitoring of antibiotics","volume":"34","author":"Ates","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.talanta.2022.123827_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/bios9010019","article-title":"Integrated microfluidic devices fabricated in poly (methyl methacrylate) (PMMA) for on-site therapeutic drug monitoring of aminoglycosides in whole blood","volume":"9","author":"Al-Aqbi","year":"2019","journal-title":"Biosensors"},{"key":"10.1016\/j.talanta.2022.123827_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.talanta.2015.04.009","article-title":"Design of a surface plasmon resonance immunoassay for therapeutic drug monitoring of amikacin","volume":"141","author":"Losoya-Leal","year":"2015","journal-title":"Talanta"},{"issue":"2","key":"10.1016\/j.talanta.2022.123827_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/jpids\/piaa024","article-title":"Determination of rifampin concentrations by urine colorimetry and mobile phone readout for personalized dosing in tuberculosis treatment","volume":"10","author":"Szipszky","year":"2021","journal-title":"J. Pediatric. Infect. Dis. Soc."},{"key":"10.1016\/j.talanta.2022.123827_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.121271","article-title":"Ion pair extraction coupled with digital image colorimetry as a rapid and green platform for pharmaceutical analysis: an example of chlorpromazine hydrochloride tablet assay","volume":"219","author":"Phadungcharoen","year":"2020","journal-title":"Talanta"},{"issue":"4","key":"10.1016\/j.talanta.2022.123827_bib25","first-page":"327","article-title":"Synthesis, Characterization and application of 2-line and 6-line ferrihydrite to Pb(II) removal from aqueous solution","volume":"16","author":"Abdus-Salam","year":"2012","journal-title":"J. Appl. Sci. Environ. Manag."},{"key":"10.1016\/j.talanta.2022.123827_bib26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1021\/es101903y","article-title":"Transformation of two-line ferrihydrite to goethite and hematite as a function of pH and temperature","volume":"45","author":"Das","year":"2011","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.talanta.2022.123827_bib27","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1021\/cm062585n","article-title":"Similarities in 2- and 6-line ferrihydrite based on pair distribution function analysis of X-ray total scattering","volume":"19","author":"Michel","year":"2007","journal-title":"Chem. Mater."},{"key":"10.1016\/j.talanta.2022.123827_bib28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1039\/C7MT00284J","article-title":"Mobilization of iron from ferritin: new steps and details","volume":"10","author":"La","year":"2018","journal-title":"Metallomics"},{"key":"10.1016\/j.talanta.2022.123827_bib29","doi-asserted-by":"crossref","first-page":"16868","DOI":"10.1039\/C9NR01541H","article-title":"On the structure and chemistry of iron oxide cores in human heart and human spleen ferritins using graphene liquid cell electron microscopy","volume":"11","author":"Narayanan","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.talanta.2022.123827_bib30","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.3390\/nu5104022","article-title":"Mobilization of stored iron in mammals: a review","volume":"5","author":"Linder","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.talanta.2022.123827_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.chemosphere.2013.10.092","article-title":"Particle size, charge and colloidal stability of humic acids coprecipitated with ferrihydrite","volume":"99","author":"Angelico","year":"2014","journal-title":"Chemosphere"},{"key":"10.1016\/j.talanta.2022.123827_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.121725","article-title":"Quantification of CRP in human serum using a handheld fluorescence detection system for capillary-based ELISA","volume":"224","author":"Morioka","year":"2021","journal-title":"Talanta"},{"issue":"10","key":"10.1016\/j.talanta.2022.123827_bib33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2116\/bunsekikagaku.64.743","article-title":"Effect of protein and inhibitors on the response of a glass capillary-type L-glutamate sensor","volume":"64","author":"Ikezawa","year":"2015","journal-title":"Bunseki Kagaku"},{"key":"10.1016\/j.talanta.2022.123827_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.sbsr.2014.10.006","article-title":"Real-time monitoring of extracellular l-glutamate levels released by high-frequency stimulation at region CA1 of hippocampal slices with a glass capillary-based l-glutamate sensor","volume":"2","author":"Ikegami","year":"2014","journal-title":"Sens. Biosensing Res."},{"key":"10.1016\/j.talanta.2022.123827_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173375","article-title":"Virology, pathogenesis, diagnosis and in-line treatment of COVID-19","volume":"883","author":"Samudrala","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.talanta.2022.123827_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2021.102560","article-title":"Clinical efficacy of Nafamostat Mesylate in combination with Favipiravir for COVID-19 pneumonia treatment review article","volume":"68","author":"Abduljabbar","year":"2021","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.talanta.2022.123827_bib37","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s13054-020-03078-z","article-title":"Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series","volume":"24","author":"Doi","year":"2020","journal-title":"Crit. Care"}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914022006233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914022006233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T16:50:08Z","timestamp":1736355008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914022006233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":37,"alternative-id":["S0039914022006233"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2022.123827","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a colorimetric assay for quantification of favipiravir in human serum using ferrihydrite","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2022.123827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123827"}}